Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-02

Clinical Trial Update: Fibroid Ablation Study [NA]

View source ↗

Summary

The fibroid ablation trial sponsored by Gynesonics has been terminated, ending the study for uterine fibroids and related menorrhagia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynesonics | Conditions: Leiomyoma, Uterine Fibroids | NA | Status: TERMINATED